Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(10%)
Results Posted
33%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_4
3
30%
Ph phase_3
2
20%
Ph phase_2
4
40%
Ph phase_1
1
10%

Phase Distribution

1

Early Stage

4

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
3(30.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
unknown1
Recruiting1
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 24 (40.0%)
Phase 32 (20.0%)
Phase 43 (30.0%)

Trials by Status

unknown110%
completed660%
recruiting110%
not_yet_recruiting110%
terminated110%

Recent Activity

1 active trials
Showing 5 of 10
terminatedphase_2

Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone

NCT05582707
completedphase_4

Effects of Pioglitazone on Exogenous Carbohydrate Oxidation During Steady-State Exercise at High Altitude

NCT06164665
recruitingphase_2

Pioglitazone Therapy Targeting Fatigue in Breast Cancer

NCT05013255
not_yet_recruitingphase_2

Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy

NCT06594172
unknownphase_4

Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD

NCT05942963
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT05582707Phase 2

Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone

Terminated
NCT06164665Phase 4

Effects of Pioglitazone on Exogenous Carbohydrate Oxidation During Steady-State Exercise at High Altitude

Completed
NCT05013255Phase 2

Pioglitazone Therapy Targeting Fatigue in Breast Cancer

Recruiting
NCT06594172Phase 2

Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy

Not Yet Recruiting
NCT05942963Phase 4

Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD

Unknown
NCT04885712Phase 3

A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Completed
NCT01161394Phase 4

Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study

Completed
NCT04883125Phase 2

Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment

Completed
NCT04671056Phase 1

Drug Interaction Study of MGL-3196 With Pioglitazone

Completed
NCT01106131Phase 3

Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10